11 insiders reported 91 Form 4 transactions for Pharvaris N.V. (PHVS) over the past 18 months (most recent 2026-08-18). Recent activity: Modig Berndt (Chief Executive Officer) Sell 2,292 shares, Lu Peng (President) Sell 109 shares, Lu Peng (President) Sell 117 shares, Modig Berndt (Chief Executive Officer) Sell 2,292 shares, Lu Peng (Chief Medical Officer) Sell 109 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Modig Berndt | Chief Executive Officer | Sell | 2,292 | $79,686 |
| 2026-08-13 | Lu Peng | President | Sell | 109 | $3,798 |
| 2026-08-13 | Lu Peng | President | Sell | 117 | $4,027 |
| 2026-07-15 | Modig Berndt | Chief Executive Officer | Sell | 2,292 | $80,154 |
| 2026-07-14 | Lu Peng | Chief Medical Officer | Sell | 109 | $3,823 |
| 2026-07-14 | Lu Peng | Chief Medical Officer | Sell | 117 | $4,103 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Sell | 2,300 | $80,786 |
| 2026-07-01 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell | 6,888 | $241,447 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 900 | $7,245 |
| 2026-07-01 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell | 30,712 | $1.1M |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 4,100 | $10,619 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 4,200 | $33,810 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 1,400 | $3,626 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Sell | 8,300 | $290,908 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 2,972 | $7,697 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Buy | 24,900 | $200,445 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Sell | 27,872 | $988,890 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Sell | 6,997 | $245,232 |
| 2026-07-01 | Lesage Anne | Chief Early Development | Sell | 30,703 | $1.1M |
| 2026-06-29 | Lu Peng | Chief Medical Officer | Buy | 15,000 | $38,850 |
| 2026-06-29 | Lesage Anne | Chief Early Development | Buy | 1,400 | $3,626 |
| 2026-06-29 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell | 2,400 | $84,250 |
| 2026-06-29 | Lu Peng | Chief Medical Officer | Sell | 11,600 | $399,675 |
| 2026-06-29 | Lesage Anne | Chief Early Development | Buy | 900 | $7,245 |
| 2026-06-29 | Lu Peng | Chief Medical Officer | Sell | 3,400 | $119,310 |
Source: SEC Form 4 filings · as of 2026-08-18